biobanking and early diagnosis to defeat nsclc
Published 6 years ago • 18 plays • Length 5:41Download video MP4
Download video MP3
Similar videos
-
4:19
biobanking of patient-derived cancer models for applied research and clinical application
-
4:13
lung cancer: early diagnosis, treatment
-
0:22
detect lung cancer early
-
4:31
impower130: pfs and safety of adding atezolizumab to first-line nsclc therapy
-
9:41
management of non-small cell lung cancer
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
6:22
prognostic biomarkers will detect lung cancer at earlier stages
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
50:40
lung cancer and mesothelioma
-
6:06
atezolizumab monotherapy vs docetaxel in 2nd and 3rd line nsclc
-
1:41
optimizing liquid biopsies for early detection in lung cancer
-
3:32
the role of ctdna in lung cancer screening
-
4:00
alectinib eclipses crizotnib for alk positive lung cancer
-
2:30
molecular testing at initial diagnosis of advanced non small cell lung cancer
-
6:39
locally advanced nsclc: staging and diagnosis
-
1:37
4. why is the biobank valuable for medical research?
-
6:09
efficacy and early discontinuation predictors in nsclc patients receiving nivolumab